Scott H. Shaffer
<p><span>Scott Shaffer, MD is assistant professor of psychiatry and behavioral sciences and pediatrics at the Albert Einstein College of Medicine. He is director of the Child and Adolescent Psychiatry Consult/Liaison Service at the Children's Hospital at Montefiore, and is the deputy training director of the child and adolescent psychiatry fellowship at the Albert Einstein College of Medicine. He completed his residency in psychiatry at the Alpert Medical School of Brown University, and his fellowship in child and adolescent psychiatry at the New York University School of Medicine. </span></p>
<p>Dr. Shaffer is a board member of the New York Council on Child and Adolescent Psychiatry. He is also chair of the Advisory Council for the Gold Humanism Honor Society and is a member of the Arnold P Gold Foundation Board of Trustees. </p>
Dr. Shaffer’s clinical focus is around the evaluation and treatment of somatic symptom disorders, autism spectrum disorder, and medical education. His research focus is on somatic symptom disorders and medical education.
<p>Samuels A, Tuvia T, Patterson D, Briklin O, <strong>Shaffer S</strong>, Walker A. <a href="https://www.ncbi.nlm.nih.gov/pubmed/31267759/">Characteristics of Conversion Disorder in an Urban Academic Children's Medical Center. </a>Clin Pediatr (Phila). 2019 Jul 3; [Epub ahead of print] PubMed PMID: 31267759.</p>
<p> </p>
<p>Denysenko L, Sica N, Penders T, Philbrick K, Walker A, <strong>Shaffer S, </strong>Zimbrean P, Freudenreich O, Rex N, Carroll B, Francis A. Catatonia in the medically ill: Etiology, Diagnosis, and treatment. The Academy of Consultation-Liaison Psychiatry Evidence-based Medicine Subcommittee Monograph. Annals of Clinical Psychiatry 2018:30(2), 140-155.</p>
<p> </p>
<p><strong>Shaffer S</strong>., Fuentes J. On or off the “Spectrum”? The complexity of screening and diagnosing autism spectrum disorder (ASD). JAACAP Connect. Volume 1 Issue 2, Fall 2014.</p>
<p><strong> </strong></p>
<p>Philip NS, <strong>Shaffer S</strong>, Banik D, Johnson B: Supportive Psychotherapy- a Crash Course for Medical Students. Academic Psychiatry 2010: 34:1, 57-60.</p>
<p>Scott Shaffer, MD, is Director of Child and Adolescent Psychiatry Consult-Liaison Service and Deputy Director of Training, Child and Adolescent Psychiatry. He is also an Assistant Professor at our Albert Einstein College of Medicine.
</p><p>After receiving his Bachelor of Arts degree in Biological Sciences from Rutgers University in 2003, Dr. Shaffer continued his education at Rutgers-Robert Wood Johnson Medical School where he earned his Doctor of Medicine degree in 2006. He earned his first residency in General Psychiatry from Warren Alpert Medical School of Brown University in 2010 and his second residency in Child and Adolescent Psychiatry from the New York University School of Medicine in 2012.
</p><p>Dr. Shaffer’s clinical focus is around the evaluation and treatment of somatic symptom disorders, autism spectrum disorder, and medical education. His research focus is on somatic symptom disorders and medical education.
</p><p>Dr. Shaffer is board certified and involved in a number of committees. He is Chair of the Nominating Committee and on the Advisory Council for the Gold Humanism Honor Society, a program of the Arnold P. Gold Foundation. Along with being a Board Member for the New York Council of the American Academy of Child and Adolescent Psychiatry he is also Co-Chair of their Medical Student Subcommittee. At the Albert Einstein College of Medicine, Dr. Shaffer serves as a co-chair for the Committee on Admissions, and is a member of the Clinical Skills Assessment Subcommittee, and the Child Psychiatry Executive Training Committee.
</p><p>He is an active member of the American Academy of Child and Adolescent Psychiatry, New York Council of the American Academy of Child and Adolescent Psychiatry, and Gold Humanism Honor Society.
</p>
Aparna V.R. Polavarapu
John J. McGinley
<p>Dr. John McGinley is Assistant Professor in Neurology at the Albert Einstein College of Medicine and the Director of Neuropsychology at the Montefiore Comprehensive Epilepsy Center. He is a Licensed Psychologist/Clinical Neuropsychologist in the Montefiore Department of Neurology. Dr. McGinley completed his clinical psychology internship in adult and pediatrics at St. Charles Hospital and Rehabilitation Center on Long Island and earned his Ph.D. in Clinical Health Psychology at the Ferkauf Graduate School of Psychology, Yeshiva University where he annually guest lecturer's on the topics of Epilepsy.</p>
<p> </p>
<p> </p>
<p style="text-align: center;"><strong>RECENT PUBLICATIONS</strong></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt; color: #222222; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Mandge V, Correa DJ, <strong>McGinley J</strong>, Boro A, Legatt AD, Haut SR. Factors associated with patients not proceeding with proposed resective epilepsy surgery. <em>Seizure</em>, 91:402-408. (2021)</span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt;"> </span></p>
<p class="MsoNormal" style="margin: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-size: 11pt; color: #201f1e; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Dobrowolski C, <strong>McGinley J</strong>, Fazzari M, Su J, Bingham KS, Anderson N, Ruttan L, Beaton DE, Wither JE, Tartaglia MC, Kakvan M, Bonilla D, Choi MY, Fritzler MJ, Diaz-Martinez JP, Katz P, Green R, Putterman C, Touma Z. (First Published online 9/22/2022). </span><span style="font-size: 11pt; color: #2a2a2a; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Association of mycophenolate and azathioprine use with cognitive function in systemic lupus. <em>Rheumatology, 62</em>(5): 1860-1869 (2023)</span></p>
<p>John McGinley, PhD, FAES, is Director, Neuropsychology, Comprehensive Epilepsy Management Center at Montefiore Einstein and Assistant Professor, Neurology at our Albert Einstein College of Medicine. Dr. McGinley's clinical focus includes the presurgical neuropsychological assessment of adults and children with epilepsy, the multidisciplinary administration of the Wada procedure and the facilitation of intraoperative language mapping. He also performs presurgical neuropsychological evaluations of patients with Parkinson's disease and other movement disorders, such as dystonia and essential tremor to assist with the determination of deep brain stimulation (DBS) suitability. Dr. McGinley also conducts brief neuropsychological evaluations for the assessment of dementia at the Center for the Aging Brain (CAB) as part of a multidisciplinary team of Neurologists, Geriatricians and Neuropsychologists.</p><p>After he obtained his Bachelor of Arts in psychology from Saint Peter's College in 1989, Dr. McGinley earned his Master of Science in applied psychology with a research concentration from the Stevens Institute of Technology in 1992. He earned his Master of Social Work at the City University of New York in 1996 and combined his clinical and research interests through the attainment of a scientist-practitioner Doctor of Philosophy in clinical health psychology at Yeshiva University. in 2001. Dr. McGinley completed his psychology internship at St. Charles Hospital & Rehabilitation Center in 2001, with postdoctoral training in pediatric neuropsychology at private practices in Long Island and New Jersey in 2007.</p><p>Dr. McGinley’s research focuses on epilepsy surgery outcomes, the impact of deep brain stimulation, the identification of biomarkers for mild cognitive impairment (MCI), shared cognitive pathways in epilepsy and autism and the impact of medications on neurological diseases such as systemic lupus. Dr. McGinley is a co-investigator for the Montefiore Einstein research project, “Effects of Deep Brain Stimulation (DBS) on Cognitive and Emotional Behaviors,” and is a collaborator on another project titled “Vocal Biomarker Discovery for Mild Cognitive Impairment Detection.” He is also the developer of a modified Wada procedure for “standard-of-care” presurgical epilepsy assessment in persons with early-onset visual impairment/blindness (VI/B). His work has been shared through numerous peer-reviewed publications and invited presentations.</p><p>Dr. McGinley is a Licensed Psychologist and a Fellow of the American Epilepsy Society (FAES) and currently serves as a member of the AES Annual Conference’s Pediatric Content Committee. He is also a member of the National Academy of Neuropsychology (NAN) and the American Academy of Neurology (AAN). In 2016, Dr. McGinley was selected to attend the inaugural “International Training Course on Neuropsychology in Epilepsy” at Château de Rosay, France, sponsored by the International League Against Epilepsy (ILAE).</p>
Fredrick J. Matzner
<p>Fredrick J. Matzner, MD, is Medical Director at the Wakefield Child and Adolescent Annex of Montefiore and Assistant Professor at our Albert Einstein College of Medicine. His clinical focus is on the development of program services for severely emotionally disturbed children and adolescents with social adversity.</p><p>In 1974, Dr. Matzner earned his Bachelor of Arts at the the University of Dallas. In 1980, he received his Doctor of Medicine at the University of Texas Southwestern Medical School. His psychiatry residency took place at New York Hospital Cornell Medical Center from 1980 to 1983. He then pursued a fellowship in child psychiatry at St. Luke’s/Roosevelt Hospital from 1983 to 1985, serving as chief resident in his final year.</p><p>Building on his clinical interests, Dr. Matzner’s research focuses primarily on multidisciplinary treatment of severe emotional disturbance in children and adolescents. His research findings have been published in several peer reviewed journals and presented at national meetings.</p><p>Dr. Matzner is board certified in Adult and Child Psychiatry, and is a member of several professional associations, including the American Academy of Child and Adolescent Psychiatry, the New York Academy of Medicine and the American Psychiatric Association.</p>
Jason P. Herrick
<p>Dr. Herrick, M.D. currently serves as the Director of Psychiatry for the Pediatric Behavioral Health Integration Program (BHIP). He has been affiliated with Montefiore and Albert Einstein College of Medicine since 2008 when he begun his psychiatry residency. He completed his Child and Adolescent fellowship in 2013 and worked briefly at the New York City Children's Center - Bronx Campus, before returning to Montefiore full time.</p>
<p>Jason Herrick, MD, is an attending physician at the Children's Hospital at Montefiore Einstein, Director, Behavioral Health at Montefiore Medical Group and Assistant Professor, Pediatrics and Psychiatry and Behavioral Sciences at our Albert Einstein College of Medicine. Dr. Herrick’s career has focused on improving access to psychiatric services across the lifespan by supporting and leading the integration of mental health services into primary care practices.</p><p>After obtaining his Post-Baccalaureate Certificate from Columbia University School of General Studies in 2004, Dr. Herrick earned his Doctor of Medicine at New York Medical College in 2008. He completed his residency in general psychiatry at the Albert Einstein College of Medicine in 2011, followed by a fellowship in child and adolescent psychiatry at the same institution in 2013.</p><p>Dr. Herrick is board certified in General Psychiatry and Child and Adolescent Psychiatry. He is a member of the American Academy of Child and Adolescent Psychiatry. </p>
Bryan M. Freilich
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Bryan M. Freilich, PsyD, ABPP-CN is Director, Neuropsychology Assessment Service and Attending Psychologist at Montefiore, as well as Assistant Professor of Psychiatry and Behavioral Science at our Albert Einstein College of Medicine. Dr. Freilich is interested in brain-behavior relationships. His clinical focus is working with children and adults with a range of neurological, psychiatric, and medical disorders. Dr. Freilich also serves as the Club Neuropsychologist for the New York City Football Club.</span></p>
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </span></p>
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">In 1997, Dr. Freilich received his bachelor’s degree in psychology at Rutgers University. He then attended Yeshiva University, Ferkauf Graduate School of Psychology, where he received his doctorate degree in clinical psychology in 2004. In 2004, Dr. Freilich completed an internship in neuropsychology at Montefiore. He began his postgraduate training in 2004 with a year-long fellowship in geropsychology at the University of Medicine and Dentistry of New Jersey / COPSA Institute for Alzheimer’s Disease and Related Disorders. Following this, Dr. Freilich completed a fellowship in neuropsychology at Montefiore in 2006.</span></p>
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </span></p>
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Dr. Freilich’s </span><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue';">clinical and research interests include dementia differential diagnosis and the neuropsychological screening and assessment of sickle cell disease, systemic lupus erythematosus, acute lymphoblastic leukemia, and traumatic brain injury/concussion. <span style="background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">His work has been published in peer-reviewed journals, books and review articles. He has also presented his work nationally at invited lectures and meetings. Dr. Freilich is board certified by the American Board of Professional Psychology and the American Board of Clinical Neuropsychology.</span></span></p>
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> </span></p>
<p class="MsoNormal" style="margin: 0in; line-height: 16.8667px; font-size: 11pt; font-family: Arial, sans-serif;"><span style="font-size: 12pt; line-height: 18.4px; font-family: 'Helvetica Neue'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">He is a member of numerous professional societies, including the American Psychological Association, the International Neuropsychological Society, the National Academy of Neuropsychology, and the New York Neuropsychology Group.</span></p>
Nicole Feirsen
<p>Nicole Feirsen, Ph.D. is a licensed clinical psychologist who specializes in neuropsychological assessments of individuals across the lifespan. She evaluates cognitive and emotional functioning in individuals with a variety of neurological, medical, and psychiatric disorders, including dementia, stroke, cancers, autoimmune diseases, epilepsy, traumatic brain injury, mood disorders, and attention disorders. Her current research is focused on the development and validation of a screening measure designed to efficiently identify cognitive impairment in a wide variety of patient populations. She earned her doctorate in clinical neuropsychology at the Graduate Center of the City University of New York and then completed her internship in clinical neuropsychology at Northwell Health. She also completed a postdoctoral fellowship in clinical neuropsychology at Montefiore Medical Center. </p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;">Freilich, B. M., <strong>Feirsen, N.</strong>, Welton, E. I., Mowrey, W. B., & Rubinstein, T. B. (2019). Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST). <em>Assessment</em>. </span><a href="https://doi.org/10.1177/1073191118822734"><span style="color: #0000ff; font-family: Calibri; font-size: medium;">https://doi.org/10.1177/1073191118822734</span></a></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;">Chacko, A., Bedard, A., Marks, D., Gopalan, G., <strong>Feirsen, N</strong>., Uderman, J., Chimiklis, A.,Rajwan, E., Cornwell, M., Anderson, L., Zwilling, A. & Ramon, M. (2018). Sequenced neurocognitive and behavioral parent training for the treatment of ADHD in school-age children. <em>Child Neuropsychology</em>, 24(4), 427-450. doi: 10.1080/09297049.2017.1282450 </span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;"> Chacko, A., Wymbs, B. T., Rajwan, E., Wymbs, F., & <strong>Feirsen, N.</strong> (2017). Characteristics of parents of children with ADHD who never attend, drop out, and complete behavioral parent training. <em>Journal of Child and Family Studies</em>, 26(3), 950-960. doi:10.1007/s10826-016-0618-z</span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;"> Chacko, A.,Bedard, A., Marks, D., <strong>Feirsen, N</strong>., Uderman, J., Chimiklis, A., Rajwan, E., Cornwell, M., Anderson, L., Zwilling, A. & Ramon, M. (2014). A randomized clinical trial of Cogmed Working Memory Training in school-age children with ADHD: A replication in a diverse sample using a control condition. <em>Journal of Child Psychology and Psychiatry</em>, 55(3), 247-55. doi: 10.1111/jcpp.12146</span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;"> Chacko, A., Uderman, J., <strong>Feirsen, N</strong>., Bedard, AC, & Marks, D. (2013). Learning and Cognitive Disorders: Multidiscipline Treatment Approaches. <em>Child and Adolescent Psychiatric Clinics of North America</em>, 22(3), 457-477.</span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;"> Chacko, A., <strong>Feirsen, N.</strong>, Bedard, A.C., Marks, D., Uderman, J., & Chimiklis, A. (2013). Cogmed Working Memory Training for Youth with ADHD: A Closer Examination of Efficacy Utilizing Evidence Based Criteria. <em>Journal of Clinical Child & Adolescent Psychology</em>, 0(0), 1-15. </span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;">Anagnostou, E., Chaplin, W., Watner, D., Silverman, J., Smith, C., Zagursky, K., Kryzak, L., Corwin, T., <strong>Feirsen, N</strong>., Tanel, N., & Hollander, E. (2011). Factor analysis of repetitive behaviors in autism as measured by the Y-BOCS. <em>Journal of Neuropsychiatry and Clinical Neuroscience</em>, 23(3), 332-339. </span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;">Chacko, A., Newcorn, J., <strong>Feirsen, N</strong>., & Uderman, J. (2010). Improving medication adherence in pediatric health conditions: A focus on ADHD in youth. <em>Current Pharmaceutical Design</em>. 2416 – 2423.</span></p>
<p> </p>
<p><span style="font-family: Calibri; font-size: medium;">Hollander, E., Chaplin, W., Soorya, L., Wasserman, S., Novotny, S., Rusoff, J., <strong>Feirsen, N</strong>., Pepa, L., & Anagnostou, L. (2009). Divalproex Sodium vs. placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. <em>Neuropharmacology</em>. 1-9.</span></p>
Nagma Dalvi
Diana Bronshteyn
Dr. Bronsheteyn's clinical focuses are on adult and geriatric populations with a range of known and suspected conditions and cognitive impairments including traumatic brain injury, cerebrovascular abnormalities, MCI, Alzheimer’s disease, Lewy Body disease, vascular dementia, Parkinson’s disease, among others.
<p>Diana Bronshteyn, PsyD, is Clinical Neuropsychologist at Montefiore. Dr. Bronshteyn brings a comprehensive understanding of various neurocognitive and neurodegenerative conditions to assess the neurologically, medically, and psychologically complex patient population. She focuses on adult and geriatric populations with a range of known and suspected conditions and cognitive impairments including traumatic brain injury, cerebrovascular abnormalities, MCI, Alzheimer’s disease, Lewy Body disease, vascular dementia, and Parkinson’s disease, among others.</p><p>After receiving her Bachelor of Arts in psychology in 2007 from Bernard Baruch College, City University of New York, Dr. Bronshteyn attended Ferkauf Graduate School of Psychology at Yeshiva University-Albert Einstein College of Medicine. She earned her Master of Arts in clinical psychology with a concentration on neuropsychology in 2011, followed by her Doctor of Psychology in the same discipline at the same institution in 2013.</p><p>Dr. Bronshteyn’s research focuses on the depressive symptoms and functional impairment in older adults. Her work has been shared through poster presentations at research conferences. </p>